HCV Testing trends. General remarks on HCV testing Trends in HCV testing in NI – An 11 year dataset RAGS- blood lab initiative- 2011-2012.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

HCV Assays: Impact on HCV Studies & Update on HCV blood bank protocol.
Identifying HIV-2 Infections Using Differential Serological Assays HIV-1 (gp41)/HIV-2(gp36) (Select HIV or MultiSpot) by Testing HIV EIA Reactive Specimens.
Unit 6 Diagnosis & Follow-up of HIV Infection
Dr. Kate Templeton SPAIIN –Stirling Overview HIV Infection Tests used in diagnostic labs How to access them Challenges HIV prevention Non –conformity.
Comparing the New EIAs with Old Standbys: Florida Bureau of Laboratories Verification Data HIV Diagnostics: New Developments and Challenges Feb. 28, 2005.
HIV Diagnostics and A New Testing Algorithm
6/03/031 Hepatitis C –Update Laboratory Issues Hema Kapoor MD. SM Virology Section Manager Bureau of Laboratories Michigan Department of Community Health.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Needs Assessment of Hepatitis C Testing, Treatment and Support Services: Survey of Laboratories in Scotland Undertaking Hepatitis C Testing.
Counseling Message: Both rapid tests we ran today were preliminary positive. It is likely that you have HIV. We always want to make absolutely sure, though,
Blood, Bugs and Biopsies Janet Moore Laboratory Manager in Cellular Pathology.
Alere TM HIV Combo Yuko Tamanoue, Product Development Department.
F. Kourgia, M. Vini, E. Zervou
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Latitude and Longitude
HIV Testing CDC power point edited by M. Myers
Screening for Acute HIV-1 Infection at NYC DOHMH Public Health Laboratory William R. Oleszko, Ph.D. Associate Director, Public Health Laboratory Department.
Incorporation of the Aptima® HIV-1 RNA Assay into Serodiagnostic and Rapid Test Confirmation Testing Algorithms to Resolve Discordant Serological Results.
Evaluation of a Proposed Testing Strategy for Laboratory-based Testing Using an HIV-1/2 Discriminatory Assay for HIV: Strategy 5 Data Needs. R. Boromisa,
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
Unmet Need for Hepatitis C PCR Testing, New York City, Emily McGibbon, MPH June 2011 CSTE Annual Conference.
HIV/AIDS is preventable and treatable, but is incurable.
HCV Diagnosis. Features of Hepatitis C Virus Infection Incubation periodAverage 6-7 weeks Range 2-26 weeks Acute illness (jaundice)Mild (
World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.
MEDICAL TESTING Doctor requires information Patient sample collection
New HIV Test Algorithms and Revised Adult HIV Case Report Form (DCH #1355) HIV Surveillance HIV/STD/VH/TB Epidemiology Section Bureau of Epidemiology Michigan.
Retrospective and Prospective U.S. Donor MRV Surveillance and Transmission Studies Michael Busch, MD, PhD Blood Systems Research Institute Dept of Laboratory.
Immunologic Laboratory Tests Kristine Krafts, M.D.
HIV diagnosis (general) ImmunoassaysNAT (PCR)
Blood Banking &Immunoassay GMS South 07-july-2010 GLOBAL MARKETING SERVICES.
HIV testing at the ICTC ICTC Team Training.
LAB. DIAGNOSIS OF VIRUSES 5 methods are used for diagnosis in the virology laboratory: 1.Direct microscopy 2.Cultivation of viruses 3.Serology 4. Detection.
Module 4: Testing and monitoring. Module 5: Testing and monitoring Module goal To introduce participants to best practice regarding the different tests,
HIV/AIDS is preventable and treatable, but is incurable.
ProgressionOf HIV Infection Cases Diagnosed in Florida Through 2011 Florida Department of Health HIV/AIDS & Hepatitis Program Annual data as of 07/31/2012.
Hepatitis C Needs Assessment: Contributions from the National HCV Diagnosis and Local Clinical Databases.
Specialties and your career. Starting work in a lab When you apply for your first job in a laboratory it will be in a specific discipline: haematology.
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid Stephen R. Lee, Keith W. Kardos, Eugene Schiff,
 Direct  Indirect  Direct: -Microscopy -Culture -Antigen -Nucleic acid  Indirect: -Specific antibody (Serology)
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report 2016.
MICROBIOLOGY PRACTICAL
Cascade of care for persons newly diagnosed
STI surveillance in Northern Ireland 2016
LAB. DIAGNOSIS OF VIRUSES
Laboratory Diagnosis of Infectious Diseases
MICROBIOLOGY PRACTICAL
Preventing and Treating STIs and HIV / AIDS
FACILITATOR VERSION Case Four: I just have antibodies to this
Do Patients adherent on PrEP exposed to HIV have seroconversion symptoms & falsely reactive HIV tests? Mark Roche1, Elaney Youssef1, Yvonne Gilleece¹,
Case Definition: HEPATITIS C
STI surveillance in Northern Ireland 2017
Program Goals Overview of HIV Epidemic HIV and Communities of Color.
Changing Technology in Diagnosis of STI
Number of HCV tests conducted
Hepatitis Primary Care: Clinics in Office Practice
Case Four: I just have antibodies to this
Virological tools to diagnose and monitor hepatitis C virus infection
Just when you thought you knew everything.
Volume 61, Issue 1, Pages S108-S119 (November 2014)
HIV surveillance in Northern Ireland 2018
STI surveillance in Northern Ireland 2018
1985: First HIV-1 ELISA Approved by FDA
FACILITATOR VERSION Case Four: I just have antibodies to this
Challenges for Blood Donor Confirmatory Testing Algorithms
Hepatitis C Testing, Treatment, Care and Support
Hepatitis C case-finding – An opportunity for community pharmacy
Presentation transcript:

HCV Testing trends

General remarks on HCV testing Trends in HCV testing in NI – An 11 year dataset RAGS- blood lab initiative

HCV infections 80% develop chronic infection 20% clear infection `

` Antibody positive PCR positive Antibody positive high level PCR negative ` Antibody positive low level PCR negative Current infection Past infection Past infection OR Spurious antibody ?

HCV Antibody tests are less perfect than HIV tests Low antibody positive PCR negative ?past infection Or ?Spurious E.g fertility occ health etc

Screening EIA (Abbott Architect) NegativeReactive <3 Reactive >3 Report: Negative Monolisa Ag/Ab NegativePositive HCV Antigen Report: Negative Report: No current infection. Either past infection or false positive antibody. Monolisa Ag/Ab NegativePositive Report: Current infection. Ask for second specimen for PCR & genotype. Suggest referral. See next slide

Screening EIA (Abbott Architect) Reactive >3 Monolisa Ag/Ab Positive PCR NegativePositive Negative Report: Negative Report: Current infection. Ask for second specimen for PCR & genotype. Suggest referral. Report: No current infection. Indicates past infection. Ask for second specimen

An estimated five out of every six UK people with chronic HCV are unaware of their infection. (2004) Diagnosed Undiagnosed

9.6% of HCV tests

15.4% Of HCV tests

5.2% of HCV tests

25.6 % of HCV tests

0.49 % of HCV tests

0.39 % of HCV tests

SourcetestedPositive% positive Belfast Northern Southern South Eastern Western GP Other TOTAL Positive results Trust/GP

SourcetestedPositive% positive OCCUPATIONAL HEALTH Fertility GUM ADDICTION RENAL Prison Positive results -Specialty

Trust positivity rate – 0.21% GP positivity rate – 0.77% Addiction positivity rate – 2.4% Prison positivity rate – 2.0%

Virology testing in NI Blood lab initiative ( ) Biochemistry Haematology Immunology Microbiology serology (including Virology) Molecular

The blood lab: RAGS Short term – Uncertainty – Diffs Longer term – Sustains virology molecular – Better TAT – Scaleable